SI3679017T1 - Kokristal oralno razpoložljivega zaviralca HIF prolil hidroksilaze - Google Patents
Kokristal oralno razpoložljivega zaviralca HIF prolil hidroksilazeInfo
- Publication number
- SI3679017T1 SI3679017T1 SI201830487T SI201830487T SI3679017T1 SI 3679017 T1 SI3679017 T1 SI 3679017T1 SI 201830487 T SI201830487 T SI 201830487T SI 201830487 T SI201830487 T SI 201830487T SI 3679017 T1 SI3679017 T1 SI 3679017T1
- Authority
- SI
- Slovenia
- Prior art keywords
- crystal
- prolyl hydroxylase
- orally available
- hydroxylase inhibitor
- hif prolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17189195 | 2017-09-04 | ||
| EP18165661 | 2018-04-04 | ||
| EP18742967.5A EP3679017B1 (en) | 2017-09-04 | 2018-07-11 | Co-crystal of an orally available hif prolyl hydroxylase inhibitor |
| PCT/EP2018/068754 WO2019042641A1 (en) | 2017-09-04 | 2018-07-11 | CO-CRYSTAL OF A HIF PROLYL HYDROXYLASE INHIBITOR AVAILABLE ORALLY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3679017T1 true SI3679017T1 (sl) | 2022-01-31 |
Family
ID=62976030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201830487T SI3679017T1 (sl) | 2017-09-04 | 2018-07-11 | Kokristal oralno razpoložljivega zaviralca HIF prolil hidroksilaze |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11192860B2 (sl) |
| EP (1) | EP3679017B1 (sl) |
| JP (1) | JP7144510B2 (sl) |
| CN (1) | CN111065625A (sl) |
| CA (1) | CA3074529C (sl) |
| CY (1) | CY1124784T1 (sl) |
| ES (1) | ES2898878T3 (sl) |
| PL (1) | PL3679017T3 (sl) |
| SI (1) | SI3679017T1 (sl) |
| WO (1) | WO2019042641A1 (sl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111320583A (zh) * | 2018-12-14 | 2020-06-23 | 广东东阳光药业有限公司 | 诺德司他新晶型及其制备方法 |
| WO2020178847A1 (en) * | 2019-03-01 | 2020-09-10 | Mylan Laboratories Limited | Cocrystal of roxadustat and d-proline |
| KR20220088743A (ko) | 2019-10-22 | 2022-06-28 | 크리스탈 파마슈티컬 (쑤저우) 씨오., 엘티디. | 저산소 유발 인자-프롤릴 하이드록실라제 억제제의 결정 형태 |
| CN111205224B (zh) * | 2020-04-22 | 2020-08-25 | 南京佰麦生物技术有限公司 | 一种罗沙司他水合物的晶型及其制备方法和应用 |
| CN114057643B (zh) * | 2020-08-04 | 2023-02-28 | 成都苑东生物制药股份有限公司 | 一种罗沙司他共晶及其制备方法 |
| RU2749719C1 (ru) * | 2020-10-08 | 2021-06-16 | Нестерук Владимир Викторович | Препарат для лечения анемии, связанной с хроническим заболеванием почек, и способ его получения |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2528232C (en) | 2003-06-06 | 2010-05-25 | Fibrogen, Inc. | Novel nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin |
| KR102029951B1 (ko) * | 2011-07-22 | 2019-11-08 | 베이징 베타 파머수티컬 컴퍼니 리미티드 | 프로릴 히드록실라제 억제제로서 화합물의 다형체형, 및 이의 용도 |
| EP2872488B1 (en) * | 2012-07-16 | 2018-08-22 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
| EP3708154A1 (en) | 2013-06-06 | 2020-09-16 | Fibrogen, Inc. | Pharmaceutical formulations of a hif hydroxylase inhibitor |
| WO2019030711A1 (en) * | 2017-08-11 | 2019-02-14 | Dr. Reddy’S Laboratories Limited | POLYMORPHS AND CO-CRYSTALS OF ROXADUSTAT |
-
2018
- 2018-07-11 WO PCT/EP2018/068754 patent/WO2019042641A1/en unknown
- 2018-07-11 CN CN201880057090.4A patent/CN111065625A/zh not_active Withdrawn
- 2018-07-11 CA CA3074529A patent/CA3074529C/en active Active
- 2018-07-11 PL PL18742967T patent/PL3679017T3/pl unknown
- 2018-07-11 ES ES18742967T patent/ES2898878T3/es active Active
- 2018-07-11 SI SI201830487T patent/SI3679017T1/sl unknown
- 2018-07-11 JP JP2020512856A patent/JP7144510B2/ja active Active
- 2018-07-11 US US16/643,886 patent/US11192860B2/en active Active
- 2018-07-11 EP EP18742967.5A patent/EP3679017B1/en active Active
-
2021
- 2021-11-24 CY CY20211101018T patent/CY1124784T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7144510B2 (ja) | 2022-09-29 |
| CA3074529A1 (en) | 2019-03-07 |
| EP3679017B1 (en) | 2021-08-25 |
| CA3074529C (en) | 2022-07-05 |
| CN111065625A (zh) | 2020-04-24 |
| ES2898878T3 (es) | 2022-03-09 |
| CY1124784T1 (el) | 2022-11-25 |
| US20200262792A1 (en) | 2020-08-20 |
| US11192860B2 (en) | 2021-12-07 |
| JP2020532559A (ja) | 2020-11-12 |
| WO2019042641A1 (en) | 2019-03-07 |
| EP3679017A1 (en) | 2020-07-15 |
| PL3679017T3 (pl) | 2022-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3679017T1 (sl) | Kokristal oralno razpoložljivega zaviralca HIF prolil hidroksilaze | |
| ZA201807865B (en) | Formulations of an lsd1 inhibitor | |
| PT3668859T (pt) | Formas sólidas de um inibidor do capsídeo do hiv | |
| EP3541932A4 (en) | CRISPR-CAS9 INHIBITORS | |
| EP3197455A4 (en) | Inhibitors of hif prolyl hydroxylase | |
| EP3414224A4 (en) | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | |
| MA41252A (fr) | Formes solides d'un inhibiteur d'ask 1 | |
| EA201692437A1 (ru) | Комбинация | |
| HK1222550A1 (zh) | 羥化酶抑制劑的藥物製劑 | |
| IL281939A (en) | VAP-1 inhibitors | |
| EP3405477C0 (en) | INHIBITORS OF TRANSGLUTAMINASE | |
| SG10202006699XA (en) | Inhibition of allergic reaction using an il-33 inhibitor | |
| EP3630742A4 (en) | CHEMILUMINESCENT PROBES FOR IMAGING / DETECTION OF PROTEASES | |
| EP3609882A4 (en) | HETEROCYCLIC INHIBITORS OF PCSK9 | |
| EP3664822A4 (en) | MICROBIAL INDUCED AMYLOID FORMATION INHIBITORS | |
| PT3458448T (pt) | Inibidores fasn para uso no tratamento de esteato-hepatite não-alcoólica | |
| IL281815A (en) | VAP-1 inhibitors | |
| EP3197452A4 (en) | Inhibitors of hif prolyl hydroxylase | |
| IL269623A (en) | Cannabidiol derivatives as activity suppressors of HIF prolyl hydroxylases | |
| EP3887356C0 (en) | MULTICOMPONENT CRYSTALS OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR | |
| EP3624782A4 (en) | INHIBITORS OF MICROBIALLY INDUCED AMYLOID | |
| EP3204385A4 (en) | Substituted pyrimidines as inhibitors of hif prolyl hydroxylase | |
| EP3419646A4 (en) | EARLY DETECTION OF HEPATOCELLULAR CARCINOMA | |
| IL264173A (en) | Solid forms of ttk inhibitor |